36321-43-4Naphazoline EP Impurity A
● 在庫あり
| カタログ番号: | VL1510001 |
|---|---|
| CAS番号: | 36321-43-4 |
| 分子式: | C₁₄H₁₆N₂O |
| 分子量: | 228.29 |
に関する追加情報 CAS 36321-43-4
親薬物
NaphazolineIUPAC名
N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamidePharmacopeial Synonyms
NaphthylacetylethylenediamineOther Synonyms
1-Naphthaleneacetamide, N-(2-aminoethyl)-; N-(2-Aminoethyl)-1-naphthaleneacetamideSMILES
C1=CC=C2C(=C1)C=CC=C2CC(=O)NCCNInChl
InChI=1S/C14H16N2O/c15-8-9-16-14(17)10-12-6-3-5-11-4-1-2-7-13(11)12/h1-7H,8-10,15H2,(H,16,17)説明
Naphazoline EP Impurity A, also referred to in pharmacopoeias as Naphthylacetylethylenediamine, is a meticulously characterized reference standard. It adheres to stringent regulatory guidelines, including those established by USP, EMA, JP, and BP. This product plays a vital role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial manufacturing of Naphazoline. Furthermore, it is accompanied by a comprehensive Structure Elucidation Report (SER), ensuring its accuracy and reliability across various analytical applications.References
“Development and Validation of a Capillary Electrophoretic Method for the Determination of Degradation Product in Naphazoline HCl Bulk Drug Substance.” Journal of Liquid Chromatography & Related Technologies, 2021, www.tandfonline.com/doi/abs/10.1080/10826079808003408.?QUAN, LIN, and HUA HE. “Treatment with Olopatadine and Naphazoline Hydrochloride Reduces Allergic Conjunctivitis in Mice through Alterations in Inflammation, NGF and VEGF.” Molecular Medicine Reports, vol. 13, no. 4, Feb. 2016, pp.見積もり依頼
「*」は必須フィールドを示します









